Terms: = Colorectal cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Diagnosis
14 results:
1. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
[TBL] [Abstract] [Full Text] [Related]
2. Dynamic regulation of EXO1 promotes the progression from liver fibrosis to HCC through TGF-β1/Smad signaling feedback loop.
Li M; Huang F; Zhu W; Peng Y; Xu F; Li W; Zhao Q; Liu L
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38126949
[TBL] [Abstract] [Full Text] [Related]
3. The TGF-β/Smad
Yu ZL; Liu J; Ning ZK; Tian HK; Wu X; Huang YF; Wu ZC; Zong Z; Zhou TC
Mol Carcinog; 2023 Feb; 62(2):261-276. PubMed ID: 36345938
[TBL] [Abstract] [Full Text] [Related]
4. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway.
Zhou H; Zou J; Shao C; Zhou A; Yu J; Chen S; Xu C
Pathol Res Pract; 2022 Feb; 230():153749. PubMed ID: 34959098
[TBL] [Abstract] [Full Text] [Related]
5. Heterotopic ossification in lymph node metastasis after rectal cancer resection: a case report and literature review.
Nagano H; Togawa T; Watanabe T; Ohnishi K; Kimura T; Iida A; Noriki S; Imamura Y; Sato Y; Goi T
World J Surg Oncol; 2021 Jan; 19(1):2. PubMed ID: 33388078
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract] [Full Text] [Related]
7. FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
Gu C; Wang X; Long T; Wang X; Zhong Y; Ma Y; Hu Z; Li Z
Cell Death Dis; 2018 May; 9(6):654. PubMed ID: 29844309
[TBL] [Abstract] [Full Text] [Related]
8. Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations.
Druliner BR; Wang P; Bae T; Baheti S; Slettedahl S; Mahoney D; Vasmatzis N; Xu H; Kim M; Bockol M; O'Brien D; Grill D; Warner N; Munoz-Gomez M; Kossick K; Johnson R; Mouchli M; Felmlee-Devine D; Washechek-Aletto J; Smyrk T; Oberg A; Wang J; Chia N; Abyzov A; Ahlquist D; Boardman LA
Sci Rep; 2018 Feb; 8(1):3161. PubMed ID: 29453410
[TBL] [Abstract] [Full Text] [Related]
9. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu J; Liu F; Li X; Song X; Zhou L; Jie J
Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ
Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634
[TBL] [Abstract] [Full Text] [Related]
12. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
Slattery ML; Herrick JS; Lundgreen A; Wolff RK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):57-69. PubMed ID: 21068203
[TBL] [Abstract] [Full Text] [Related]
13. [Intraepithelial neoplasia in ulcerative colitis: on the way to more diagnostic confidence].
Baretton GB; Aust DE
Verh Dtsch Ges Pathol; 2007; 91():126-34. PubMed ID: 18314606
[TBL] [Abstract] [Full Text] [Related]
14. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
[TBL] [Abstract] [Full Text] [Related]
